In 2023, Russia registered 30 vaccines and 81 pharmaceuticals for animals
29 December 2023
As part of import substitution, Russian manufacturers registered 30 veterinary vaccines and 81 pharmaceutical products for animals in 2023, the press service of the Federal Service for Veterinary and Phytosanitary Supervision (Rosselkhoznadzor) reported to Veterinary and Life Journal. In addition, in 2022, 22 Russian veterinary vaccines and 74 pharmaceuticals were registered for the purpose of import substitution.
Additional 1.6 billion rubles for goods and equipment in federal budget
28 December 2023
Prime Minister of the Russian Federation Mikhail Mishustin signed order No. 3881-r dated December 23, 2023, according to which an additional 1.6 billion rubles will be allocated from the reserve fund to provide disabled people with technical means of rehabilitation.
In November, Russia produced drugs worth 61 billion rubles
28 December 2023
According to the Federal State Statistics Service – Rosstat, the production of medicines in Russia in November 2023 increased by 33% compared to the same period last year – to 61 billion rubles.
2024 forecast: Digital therapeutics makers will have to get creative to conquer reimbursement issues
27 December 2023
The science behind digital therapeutics may sound dubious on paper—a smartphone app that can help someone quit smoking, reverse Type 2 diabetes or treat depression.
FDA approves Glaukos’ iDose TR treatment for glaucoma disease
26 December 2023
Glaukos Corporation has announced that the US Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for a single administration per eye of iDose TR (travoprost intracameral implant) 75mcg, a prostaglandin analogue which is indicated for the reduction of intraocular pressure (IOP) in patients diagnosed with either ocular hypertension (OHT) or open-angle glaucoma (OAG).
2024 forecast: Will generative AI find what it needs to deliver for patients?
26 December 2023
Large language programs such as ChatGPT and its followers have hogged the spotlight this year, leaving their audience calling for new debates on their ethics and safety. But as the medtech industry watches from the wings—hearing that artificial intelligence has finally, finally arrived and will now begin to reshape our lives, for good or ill—many developers in healthcare are wondering where people have been for the past decade.
FDA Publishes Guidance on Real-Word Data
25 December 2023
The final guidance document provides recommendations for designing a new registry or using an existing registry to support decisions regarding safety and effectiveness of a drug.
Newly-identified flu antibodies could form the basis of better vaccines
25 December 2023
A major bump in the road to building broader, more durable vaccines may not be as much of a hurdle as scientists once thought, new research suggests.
Year in review: EPR’s top stories of 2023
22 December 2023
EPR wraps up the year with a selection of top stories from 2023, highlighting key trends and topics such as environmental monitoring (EM), quality (QA/QC), manufacturing, regulation and clinical development.
European regulators prepare for AI in pharma
21 December 2023
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMAs) have published a plan, which sets out a “collaborative and coordinated strategy” to maximise the benefits of artificial intelligence in regulation.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russia has expanded the mandatory health insurance program for 2024-2026
29 March 2024
Russian scientists have developed new TB vaccines for both injection and nasal administration.
29 March 2024
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024